$397M
$1.5 Billion
0.28% of portfolio
320,727
Q2 2024
Reduced 29.76%
$169M
$1.26 Billion
0.24% of portfolio
138,158
Q2 2024
Added 2,869.86%
$29.7M
$1.29 Billion
0.24% of portfolio
645,161
Q2 2024
Added 213.29%
$45.9M
$1.19 Billion
0.23% of portfolio
918,929
Q2 2024
Reduced 0.86%
-
$1.2 Billion
0.23% of portfolio
-
Q2 2024
Reduced 5.0%
$163B
$1.12 Billion
0.21% of portfolio
39,950
Q2 2024
Reduced 62.43%
-
$1.13 Billion
0.21% of portfolio
-
Q2 2024
Added 153.64%
$30.7M
$1.06 Billion
0.2% of portfolio
201,728
Q1 2024
New
$2.34B
$982 Million
0.19% of portfolio
34,000
Q2 2024
Added 100.0%
$721M
$990 Million
0.19% of portfolio
113,626
Q2 2024
New
$999M
$979 Million
0.18% of portfolio
110,000
Q2 2024
New
$784M
$929 Million
0.18% of portfolio
53,261
Q2 2024
New
$6.71B
$925 Million
0.17% of portfolio
12,250
Q2 2024
Added 512.5%
$406M
$887 Million
0.17% of portfolio
195,311
Q2 2024
Added 272.02%
$3.95B
$882 Million
0.17% of portfolio
38,000
Q2 2024
Added 1,800.0%
$374M
$890 Million
0.17% of portfolio
60,000
Q2 2024
New
$1.32B
$862 Million
0.16% of portfolio
32,400
Q2 2024
Added 23.66%
$300M
$870 Million
0.16% of portfolio
143,862
Q2 2024
Reduced 6.19%
-
$827 Million
0.16% of portfolio
-
Q2 2024
Reduced 28.93%
$3.24B
$792 Million
0.15% of portfolio
20,650
Q2 2024
Reduced 19.65%
$13.8B
$817 Million
0.15% of portfolio
23,000
Q2 2024
New
Keen Vision Acquisition Corp
-
$793 Million
0.15% of portfolio
-
Q4 2023
New
Kiora Pharmaceuticals Inc
-
$725 Million
0.14% of portfolio
-
Q2 2024
New
$655M
$766 Million
0.14% of portfolio
40,290
Q2 2024
Added 0.5%
$132M
$695 Million
0.13% of portfolio
97,695
Q2 2024
New
$10.9B
$703 Million
0.13% of portfolio
4,450
Q2 2024
Reduced 85.69%
$79.1M
$698 Million
0.13% of portfolio
572,170
Q2 2024
Added 269.14%
Perspective Therapeutics Inc
-
$698 Million
0.13% of portfolio
-
Q2 2024
New
$0
$614 Million
0.12% of portfolio
53,527
Q2 2024
Added 30.78%
$36.9M
$652 Million
0.12% of portfolio
1,086,498
Q2 2024
Added 359.17%
$104M
$631 Million
0.12% of portfolio
945,568
Q2 2024
New
$10.8M
$658 Million
0.12% of portfolio
1,225,270
Q2 2024
Added 1.7%
$42.1B
$615 Million
0.12% of portfolio
11,400
Q2 2024
Reduced 69.52%
$1.31B
$598 Million
0.11% of portfolio
25,507
Q2 2024
Added 1,311.57%
$100M
$562 Million
0.11% of portfolio
250,800
Q2 2024
Added 476.55%
-
$549 Million
0.1% of portfolio
-
Q4 2023
New
$45.3M
$556 Million
0.1% of portfolio
75,133
Q2 2024
Reduced 24.87%
-
$505 Million
0.1% of portfolio
-
Q4 2023
New
$994M
$519 Million
0.1% of portfolio
70,000
Q2 2024
New
$2.86B
$534 Million
0.1% of portfolio
13,000
Q2 2024
Added 4.84%
Corbus Pharmaceuticals Hldgs
-
$543 Million
0.1% of portfolio
-
Q2 2024
Reduced 25.0%
$35M
$480 Million
0.09% of portfolio
113,125
Q2 2024
New
$90.2M
$480 Million
0.09% of portfolio
532,628
Q2 2024
Reduced 27.3%
$5.65B
$495 Million
0.09% of portfolio
27,000
Q2 2024
Added 74.19%
$1.04B
$484 Million
0.09% of portfolio
35,100
Q2 2024
New
$0
$497 Million
0.09% of portfolio
10,000
Q4 2023
New
$9.61M
$401 Million
0.08% of portfolio
355,240
Q2 2024
New
-
$447 Million
0.08% of portfolio
-
Q2 2024
New
-
$406 Million
0.08% of portfolio
-
Q2 2024
Added 526.83%
-
$435 Million
0.08% of portfolio
-
Q2 2024
Reduced 0.73%